Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP930208.RAi_AQ-jfkN7EcS6AlfpHvFLi3_j2BCwXRlRVbazRacFQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP930208.RAi_AQ-jfkN7EcS6AlfpHvFLi3_j2BCwXRlRVbazRacFQ130_assertion type Assertion NP930208.RAi_AQ-jfkN7EcS6AlfpHvFLi3_j2BCwXRlRVbazRacFQ130_head.
- NP930208.RAi_AQ-jfkN7EcS6AlfpHvFLi3_j2BCwXRlRVbazRacFQ130_assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP930208.RAi_AQ-jfkN7EcS6AlfpHvFLi3_j2BCwXRlRVbazRacFQ130_provenance.
- NP930208.RAi_AQ-jfkN7EcS6AlfpHvFLi3_j2BCwXRlRVbazRacFQ130_assertion evidence source_evidence_literature NP930208.RAi_AQ-jfkN7EcS6AlfpHvFLi3_j2BCwXRlRVbazRacFQ130_provenance.
- NP930208.RAi_AQ-jfkN7EcS6AlfpHvFLi3_j2BCwXRlRVbazRacFQ130_assertion SIO_000772 11877595 NP930208.RAi_AQ-jfkN7EcS6AlfpHvFLi3_j2BCwXRlRVbazRacFQ130_provenance.
- NP930208.RAi_AQ-jfkN7EcS6AlfpHvFLi3_j2BCwXRlRVbazRacFQ130_assertion wasDerivedFrom befree-20140225 NP930208.RAi_AQ-jfkN7EcS6AlfpHvFLi3_j2BCwXRlRVbazRacFQ130_provenance.
- NP930208.RAi_AQ-jfkN7EcS6AlfpHvFLi3_j2BCwXRlRVbazRacFQ130_assertion wasGeneratedBy ECO_0000203 NP930208.RAi_AQ-jfkN7EcS6AlfpHvFLi3_j2BCwXRlRVbazRacFQ130_provenance.